GHK-Cu nasal spray for skin: what the science says

What's this video probably claiming?

Based on the caption and hashtags, this video is almost certainly presenting a before/after or progress narrative around a client using GHK-Cu delivered via nasal spray, framed as an anti-aging and skin glow treatment. The creator references "subtle changes in the first week" and promises a transformation arc. That framing implies the nasal spray route is delivering cosmetically meaningful results to the skin, and that GHK-Cu is a legitimate aesthetic intervention. The hashtags lean hard into beauty influencer territory, which means the audience is probably not peptide researchers. They're people looking for the next glow protocol. The implicit claim here is that systemic GHK-Cu administration, through nasal absorption, produces visible skin improvements within days. That's a layered claim, and each layer deserves scrutiny.

What does the science actually show?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has a legitimate research history, mostly in topical applications. Pickart et al. (2015, Journal of Aging Science) documented GHK-Cu's role in stimulating collagen synthesis, activating wound healing pathways, and influencing gene expression related to skin remodeling. In vitro studies show it upregulates collagen I and III production. Leyden et al. published data showing topical GHK-Cu improved skin elasticity and density in a 12-week controlled trial. However, the keyword there is topical. The nasal delivery route for cosmetic skin outcomes has essentially no peer-reviewed clinical backing. Nasal peptide absorption is studied primarily for CNS and systemic systemic signaling effects, not dermal remodeling. Claiming skin changes in week one from nasal GHK-Cu falls well outside what published human data actually supports.

Where does the social media noise diverge from clinical reality?

The gap here is significant on two fronts. First, route of administration. Topical GHK-Cu is the evidence-based delivery method for skin outcomes. It works locally, at the dermis level. Nasal spray delivers peptide systemically via olfactory and mucosal absorption, a completely different pharmacokinetic pathway that hasn't been validated for cosmetic skin endpoints in any randomized controlled trial. Second, timeline. Collagen synthesis and dermal remodeling are slow biological processes. Clinical trials showing measurable skin improvement from GHK-Cu typically run 8 to 12 weeks minimum, and that's with topical application. "Subtle changes in week one" from a nasal spray is almost certainly a placebo effect, lighting difference, or skin hydration artifact. Social media thrives on early transformation content. The science doesn't support week-one skin structural changes from this delivery method.

What should you actually know?

GHK-Cu is a real compound with real research behind it, but the context matters enormously. If you're evaluating peptide therapy with a licensed provider, topical formulations have the most evidence for skin applications. Systemic delivery routes, including nasal spray, are being explored for other indications but cosmetic skin improvement via nasal GHK-Cu is not an established clinical use. The compounded nasal spray market exists largely ahead of the clinical trial data that would actually justify specific outcome claims. Anyone presenting week-one skin transformation photos from a nasal spray should be asked a simple question: what's the control? One client's perceived glow isn't a data point. Beyond efficacy, compounded peptide quality, sterility standards, and dosing consistency in the nasal spray format vary significantly between compounders. A regulated telehealth provider should be transparent about what evidence supports each delivery method and what remains investigational.